SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 141 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $141 | -99.9% | 5,403 | -26.3% | 0.00% | 0.0% |
| Q2 2022 | $181,000 | -85.9% | 7,335 | -67.8% | 0.00% | -77.8% |
| Q1 2022 | $1,287,000 | -37.6% | 22,810 | -31.5% | 0.01% | -18.2% |
| Q4 2021 | $2,063,000 | +54.1% | 33,287 | +57.7% | 0.01% | +83.3% |
| Q3 2021 | $1,339,000 | -15.9% | 21,108 | +9.2% | 0.01% | -14.3% |
| Q2 2021 | $1,593,000 | +28.4% | 19,326 | +14.5% | 0.01% | +16.7% |
| Q1 2021 | $1,241,000 | -25.8% | 16,875 | -26.9% | 0.01% | -33.3% |
| Q4 2020 | $1,673,000 | -15.0% | 23,073 | -44.1% | 0.01% | -30.8% |
| Q3 2020 | $1,969,000 | +303.5% | 41,304 | +255.7% | 0.01% | +225.0% |
| Q2 2020 | $488,000 | +269.7% | 11,611 | +138.0% | 0.00% | +300.0% |
| Q1 2020 | $132,000 | – | 4,878 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
| Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
| Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
| Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
| Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
| Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
| Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |